Prenatal Care Practice Questions

Q: When heparin is administered during pregnancy, which of the following supplements should be added?

Calcium. **Explanation:** The correct answer is **Calcium**. **Why Calcium is the correct answer:** Long-term administration of heparin (both Unfractionated Heparin and Low Molecular Weight Heparin) during pregnancy is associated with a risk of **heparin-induced osteoporosis**. Heparin accelerates the loss of bone mineral density by increasing osteoclast activity and decreasing osteoblast function. Since pregnancy itself is a state of high calcium demand for fetal skeletal development, heparin therapy further predisposes the mother to bone loss and fractures. Therefore, supplemental **Calcium (1000–1500 mg/day)** and **Vitamin D** are routinely recommended to mitigate this risk. **Why other options are incorrect:** * **Iron and Folic Acid:** While these are standard supplements for all pregnant women to prevent anemia and neural tube defects, their requirement is not specifically linked to heparin administration. * **Copper and Zinc:** These are trace elements. Heparin does not interfere with their metabolism or absorption, and there is no clinical indication to supplement them specifically due to heparin therapy. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Heparin (specifically LMWH like Enoxaparin) is the anticoagulant of choice in pregnancy because it **does not cross the placenta** and is not teratogenic (unlike Warfarin, which causes Fetal Warfarin Syndrome). * **Monitoring:** LMWH does not require routine PT/INR or aPTT monitoring. If monitoring is needed (e.g., in renal failure or extreme obesity), **Anti-Xa levels** are measured. * **Side Effects:** The two most important side effects of heparin in pregnancy are **Osteoporosis** and **Heparin-Induced Thrombocytopenia (HIT)**. * **Timing:** Heparin should be discontinued 12–24 hours before planned induction or regional anesthesia to reduce the risk of spinal hematoma.

Q: All of the following are ultrasonographic fetal growth parameters EXCEPT?

Transcerebeller diameter. In fetal ultrasonography, parameters are categorized into those used for **dating** (gestational age) and those used for **growth assessment**. ### Why Transcerebellar Diameter (TCD) is the Correct Answer The **Transcerebellar Diameter (TCD)** is highly resistant to growth restriction (IUGR). Because the cerebellum's growth is relatively independent of external factors and fetal nutrition, it remains a reliable indicator of **gestational age (dating)**, even when the fetus is growth-restricted. It is not used to monitor or calculate fetal weight/growth. ### Explanation of Incorrect Options (Growth Parameters) The other three parameters are the standard components used in the **Hadlock Formula** to estimate fetal weight and assess growth: * **Biparietal Diameter (BPD):** Measures the width of the fetal head. While used for dating in the second trimester, it is a core component of growth assessment. * **Head Circumference (HC):** A more reliable indicator of head growth than BPD, especially if the head is flattened (dolichocephaly) or rounded (brachycephaly). * **Femur Length (FL):** Reflects the longitudinal growth of the fetus and is the most reliable long-bone parameter for growth. * *(Note: Abdominal Circumference (AC) is the most sensitive single parameter for fetal growth/IUGR, though not listed in the options).* ### High-Yield Clinical Pearls for NEET-PG * **Best parameter for dating (1st Trimester):** Crown-Rump Length (CRL). * **Best parameter for dating (2nd Trimester):** Transcerebellar Diameter (TCD). * **Most sensitive parameter for IUGR:** Abdominal Circumference (AC). * **TCD Rule of Thumb:** Between 14 and 20 weeks, the TCD in millimeters is roughly equal to the gestational age in weeks.

Q: Which of the following trace elements cannot be completely supplemented by diet in pregnancy?

Iron (Fe). **Explanation:** The correct answer is **Iron (Fe)**. During pregnancy, the total iron requirement is approximately **1000 mg** (300 mg for the fetus/placenta, 500 mg for maternal red cell mass expansion, and 200 mg for obligatory losses). This demand increases significantly in the second and third trimesters, reaching up to 6–7 mg/day. Even with a balanced diet rich in heme and non-heme iron, the maximum absorption from the gut is limited. Therefore, dietary intake alone cannot meet these physiological demands, making routine oral iron supplementation (60 mg elemental iron daily as per WHO/GOI guidelines) mandatory for all pregnant women. **Analysis of Incorrect Options:** * **Calcium (Ca++):** While the demand for calcium increases (approx. 30g total), it can theoretically be met through a diet rich in dairy products and green leafy vegetables. However, supplementation is often given to prevent hypertensive disorders (Preeclampsia). * **Zinc (Zn):** Zinc requirements increase slightly during pregnancy for fetal growth, but the amounts required are small enough to be easily obtained from a standard diet containing nuts, legumes, and meat. * **Manganese:** This is a trace element required in minute quantities. Deficiencies are extremely rare as it is abundant in whole grains and vegetables; thus, routine supplementation is never required. **High-Yield Clinical Pearls for NEET-PG:** * **Iron absorption:** It is maximal in the duodenum and upper jejunum. Absorption is enhanced by Vitamin C and inhibited by tea, coffee, and calcium. * **Prophylactic Dose (IFA):** 60 mg elemental iron + 500 mcg Folic acid for 180 days (starting from the 14th week). * **Therapeutic Dose:** 120 mg elemental iron daily if the patient is diagnosed with anemia. * **Folic Acid:** While not a trace element, it is the only other nutrient (besides Iron) that cannot be met by diet alone to prevent Neural Tube Defects (NTDs).

Q: Which of the following screening tests is NOT recommended by the CDC in pregnant females?

Saline microscopy for bacterial vaginosis. **Explanation:** The correct answer is **D. Saline microscopy for bacterial vaginosis.** According to the **CDC and USPSTF guidelines**, universal screening for Bacterial Vaginosis (BV) in asymptomatic pregnant women is **not recommended**. Clinical trials have shown that screening and treating asymptomatic BV does not significantly reduce the risk of preterm birth or other adverse pregnancy outcomes in the general obstetric population. Therefore, testing (via saline microscopy for Clue cells or Whiff test) is reserved only for symptomatic patients. **Analysis of Incorrect Options:** * **A. ELISA for HIV:** Universal "opt-out" screening is mandatory at the first prenatal visit. Early detection allows for HAART initiation, which reduces vertical transmission from ~25% to <1%. * **B. HBsAg:** Screening for Hepatitis B surface antigen is mandatory for all pregnant women at the first visit to identify neonates requiring immunoprophylaxis (HBIG + Vaccine) at birth. * **C. NAAT for Chlamydia and Gonorrhea:** The CDC recommends universal screening for Chlamydia in all pregnant women <25 years (and older women at high risk). Screening for Gonorrhea is recommended for those at increased risk. **High-Yield Clinical Pearls for NEET-PG:** * **Syphilis:** Universal screening via serology (VDRL/RPR) is mandatory at the first visit. * **GBS (Group B Strep):** Universal screening via vaginal-rectal swab is performed at **36 0/7 to 37 6/7 weeks** of gestation. * **Diabetes:** Universal screening for GDM is done at **24–28 weeks** using the OGTT (DIPSI or IADPSG criteria). * **Bacteriuria:** Screening for **Asymptomatic Bacteriuria** (via urine culture) is mandatory at 12–16 weeks to prevent pyelonephritis.

Q: Glucosuria noted during a routine antenatal investigation indicates the need for what next step?

Glucose tolerance test. **Explanation:** The correct answer is **D. Glucose tolerance test**. **1. Why the correct answer is right:** During pregnancy, the **Glomerular Filtration Rate (GFR) increases** by approximately 50%, while the renal tubular reabsorption capacity for glucose remains unchanged or slightly decreases. This leads to a lowered renal threshold for glucose, making **isolated glucosuria a common and often physiological finding** in up to 50% of pregnant women. However, because glucosuria can also be a marker for undiagnosed Gestational Diabetes Mellitus (GDM), it cannot be ignored. It serves as a screening signal that necessitates a definitive diagnostic step—the **Glucose Tolerance Test (GTT)**—to differentiate between physiological renal changes and true carbohydrate intolerance. **2. Why the incorrect options are wrong:** * **A & C (Treatment/Insulin):** One cannot initiate treatment or insulin therapy based solely on a urine dipstick. Diagnosis must first be confirmed via standardized blood glucose testing (OGTT/DIPSI). * **B (Dietary modification):** While healthy eating is encouraged, formal dietary modification as a medical intervention for GDM is only prescribed after a confirmed diagnosis. **3. NEET-PG High-Yield Pearls:** * **DIPSI Criteria:** In India, the Diabetes in Pregnancy Study Group India (DIPSI) recommends a 75g oral glucose load regardless of the last meal. A 2-hour plasma glucose **≥140 mg/dL** is diagnostic of GDM. * **Renal Threshold:** In non-pregnant adults, the renal threshold for glucose is ~180 mg/dL; in pregnancy, this threshold drops significantly. * **hPL Factor:** Human Placental Lactogen (hPL) is the primary hormone responsible for the "diabetogenic" state of pregnancy, peaking in the third trimester.

Q: A 22-year-old woman at 14 weeks gestation presents for routine antenatal testing. Her urine dipstick is positive for leukocyte esterase, and a subsequent urine culture reveals E. coli with >100,000 organisms/mL. The patient reports no urinary symptoms. Which of the following statements regarding her condition is false?

No treatment is warranted as the patient is asymptomatic.. **Explanation:** The patient has **Asymptomatic Bacteriuria (ASB)**, defined as the presence of >10^5 colony-forming units (CFU)/mL of a single uropathogen in a midstream clean-catch urine specimen from an individual without symptoms of a urinary tract infection (UTI). **1. Why Option C is the Correct Answer (False Statement):** In non-pregnant individuals, ASB is often left untreated. However, **pregnancy is a mandatory indication for treatment.** Physiological changes (progesterone-mediated ureteral dilation and bladder relaxation) increase the risk of ascending infection. Treating ASB significantly reduces the risk of maternal and fetal complications. Therefore, the statement that "no treatment is warranted" is medically incorrect. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** Untreated ASB is strongly associated with adverse pregnancy outcomes, including **preterm labor (PTL)** and **low birth weight (LBW)** infants. * **Option B:** There is a documented increased incidence of ASB in pregnant women with **Sickle Cell Trait** and Diabetes Mellitus. * **Option C:** If left untreated, approximately **25–40%** of pregnant women with ASB will develop **acute pyelonephritis**, which can lead to maternal sepsis and ARDS. **Clinical Pearls for NEET-PG:** * **Screening:** All pregnant women should be screened for ASB at the first prenatal visit (ideally between 12–16 weeks) using a **urine culture** (Gold Standard). * **Treatment:** Common first-line agents include **Nitrofurantoin** (avoid near term due to risk of fetal hemolysis), **Amoxicillin**, or **Cephalexin**. * **Follow-up:** A repeat urine culture ("test of cure") is mandatory 1–2 weeks after completing treatment.

Q: Nuchal translucency thickness is typically evaluated during which antenatal ultrasound examination?

Second trimester. **Explanation:** The evaluation of **Nuchal Translucency (NT)** is a critical component of the **First Trimester Screening** (Option A). However, based on the specific options provided and the context of standard antenatal protocols, the question refers to the timing of the examination. * **Correct Answer (A/First Trimester):** NT is the sonographic appearance of a collection of fluid under the skin behind the fetal neck. It is measured strictly between **11 weeks and 13 weeks 6 days** of gestation (CRL 45–84 mm). An increased NT thickness is associated with chromosomal abnormalities (most commonly Trisomy 21), structural heart defects, and other genetic syndromes. * **Why Option C (Second Trimester) is technically incorrect for NT:** In the second trimester (18–22 weeks), the equivalent marker is called **Nuchal Fold (NF)** thickness. While NT disappears after 14 weeks, an increased Nuchal Fold (>6 mm) is a soft marker for Down syndrome during the second-trimester anomaly scan. *(Note: If the provided key insists on "Second Trimester," it likely confuses NT with Nuchal Fold; however, in standard medical literature, NT is strictly a first-trimester marker.)* **Incorrect Options:** * **Prenatal screening (B):** This is a broad category of testing, not a specific ultrasound examination period. * **Third trimester (D):** Scans at this stage focus on fetal growth, liquor volume, and placental position; NT/NF are no longer valid markers here. **High-Yield Clinical Pearls for NEET-PG:** * **NT Cut-off:** Generally considered abnormal if **>3.0 mm** or above the 95th percentile for CRL. * **Nuchal Fold (NF):** Measured in the second trimester; abnormal if **>6 mm**. * **Combined Screening:** Includes NT measurement + Serum PAPP-A + Free β-hCG. * **Nasal Bone:** Absence of the nasal bone during the NT scan further increases the risk for Trisomy 21.

Q: What is the best treatment for condyloma acuminata during pregnancy?

Cryotherapy. **Explanation:** **Condyloma acuminata** (anogenital warts) are caused by Human Papillomavirus (HPV), typically types 6 and 11. During pregnancy, these lesions often proliferate and become more vascular due to hormonal changes and relative immunosuppression. **Why Cryotherapy is the Correct Answer:** Cryotherapy (using liquid nitrogen) is considered a first-line treatment during pregnancy because it is a **physical ablation** method. It is highly effective, has a low systemic absorption profile, and is safe for the fetus. While Trichloroacetic acid (TCA) is also safe, cryotherapy is often preferred in clinical practice for its rapid action and controlled application. **Analysis of Incorrect Options:** * **A. Podophyllin:** This is **contraindicated** in pregnancy. It is antimitotic and can be systemically absorbed, leading to potential fetal death, teratogenicity, or maternal toxicity (peripheral neuropathy, coma). * **C. Trichloroacetic acid (TCA):** While TCA is safe to use in pregnancy (it acts by chemical coagulation of proteins), it is generally considered secondary to physical methods like cryotherapy or laser for extensive lesions. * **D. 5-FU cream:** This is **contraindicated** (Category X) due to its interference with DNA synthesis, posing a significant risk of teratogenicity. **High-Yield Clinical Pearls for NEET-PG:** * **Mode of Delivery:** The presence of genital warts is **not** an absolute indication for Cesarean section. C-section is only indicated if the warts are so large they obstruct the birth canal or if vaginal delivery would result in massive hemorrhage. * **Juvenile Laryngeal Papillomatosis:** This is a rare but serious complication in the neonate caused by vertical transmission of HPV 6/11. However, C-section does not reliably prevent this transmission. * **Imiquimod:** Also generally avoided in pregnancy due to limited safety data.

Question 1

When heparin is administered during pregnancy, which of the following supplements should be added?

Accepted Answer

Calcium

Answer

Iron folic acid

Answer

Copper

Answer

Zinc

Question 2

All of the following are ultrasonographic fetal growth parameters EXCEPT?

Accepted Answer

Transcerebeller diameter

Answer

Biparietal diameter

Answer

Head circumference

Answer

Femur length

Question 3

Which of the following trace elements cannot be completely supplemented by diet in pregnancy?

Accepted Answer

Iron (Fe)

Answer

Calcium (Ca++)

Answer

Zinc (Zn)

Answer

Manganese

Question 4

Which of the following screening tests is NOT recommended by the CDC in pregnant females?

Accepted Answer

Saline microscopy for bacterial vaginosis

Answer

ELISA for HIV

Answer

HBsAg

Answer

NAAT for Chlamydia and Gonorrhea

Question 5

Glucosuria noted during a routine antenatal investigation indicates the need for what next step?

Accepted Answer

Glucose tolerance test

Answer

Treatment for gestational diabetes

Answer

Dietary modification

Answer

Insulin therapy

Question 6

Which cardiovascular change is physiological in the last trimester of pregnancy?

Accepted Answer

Shift of apical impulse laterally and upwards in the left 4th intercostal space

Answer

Middiastolic murmur

Answer

Occasional atrial fibrillation

Answer

Cardiomegaly

Question 7

A 22-year-old woman at 14 weeks gestation presents for routine antenatal testing. Her urine dipstick is positive for leukocyte esterase, and a subsequent urine culture reveals E. coli with >100,000 organisms/mL. The patient reports no urinary symptoms. Which of the following statements regarding her condition is false?

Accepted Answer

No treatment is warranted as the patient is asymptomatic.

Answer

Asymptomatic bacteriuria in pregnancy is associated with preterm delivery and low birth weight.

Answer

There is an increased incidence of asymptomatic bacteriuria in women with sickle cell trait.

Answer

Approximately 25% of patients with asymptomatic bacteriuria will subsequently develop an acute symptomatic urinary infection during pregnancy if left untreated.

Question 8

Nuchal translucency thickness is typically evaluated during which antenatal ultrasound examination?

Accepted Answer

Second trimester

Answer

First trimester

Answer

Prenatal screening

Answer

Third trimester

Question 9

What is the best treatment for condyloma acuminata during pregnancy?

Accepted Answer

Cryotherapy

Answer

Podophyllin

Answer

Trichloroacetic acid

Answer

5-FU cream

Question 10

A patient who works as a nurse in the surgery intensive care unit at a local community hospital plans to discontinue her oral contraceptives to attempt pregnancy in the next few months. She has questions regarding updating her immunizations and whether they can be administered during pregnancy. Which of the following statements regarding immunizations and pregnancy is FALSE?

Accepted Answer

The patient should be given the tetanus toxoid vaccination prior to becoming pregnant because it is a live virus that has been associated with multiple fetal anomalies when administered during pregnancy.

Answer

The patient should be checked for immunity against the rubella virus prior to conception because the rubella vaccine is a live virus and should not be given during pregnancy.

Answer

The Centers for Disease Control and Prevention recommends that all pregnant women should be vaccinated against the influenza virus after the first trimester.

Answer

If the patient does not have a history of having chickenpox in the past, she should be screened for immunity because most people without a history of the infection are immune; if the patient is nonimmune, she should be given the vaccine prior to achieving pregnancy because the vaccine is a live virus.

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?